Mega Lifesciences Ownership

MEGA Stock  THB 35.25  0.25  0.70%   
Mega Lifesciences Public maintains a total of 871.87 Million outstanding shares. Mega Lifesciences Public secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.85 % of Mega Lifesciences Public outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Mega Lifesciences in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Mega Lifesciences, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mega Lifesciences Public. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.

Mega Stock Ownership Analysis

About 61.0% of the company outstanding shares are owned by corporate insiders. The book value of Mega Lifesciences was now reported as 9.78. The company last dividend was issued on the 24th of August 2022. Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures, markets, and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast moving consumer goods. Mega Lifesciences Public Company Limited is a subsidiary of Unistretch Limited. MEGA LIFESCIENCES operates under Drug Manufacturers - Major classification in Thailand and is traded on Stock Exchange of Thailand. To find out more about Mega Lifesciences Public contact Vivek Dhawan at 66 2 769 4222 or learn more at https://www.megawecare.com.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Mega Stock

Mega Lifesciences financial ratios help investors to determine whether Mega Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mega with respect to the benefits of owning Mega Lifesciences security.